Here’s a summary of the latest earnings and operational updates in the cannabis industry.
InMed Pharmaceuticals Posts Record Net Loss Of $11.9M
The Vancouver-based company posted a record net loss of $11.9 million, versus a net loss of $13.3 million for the last year.
In addition, its research and development expenses were $7.1 million, up by around 27% compared to the previous year.
Its general and administrative expenses decreased by approximately 8% over the year to $3.5 million.
The company’s cash equivalents and short-term investments amounted to $8 …